Fig. 6.
Fig. 6. Immunization with Vacc.polyLMP affords protection against LMP1-expressing EL4-A2/kb tumor cells. / Two groups of 10 mice were immunized with Vacc.polyLMP or Vacc.TK− (107 PFU/mouse), respectively. Twenty-one days after immunization, mice were challenged subcutaneously with EL4-A2/Kb-LMP1 cells (107 cell/mouse) and monitored for tumor size for 24 days after challenge. Data are presented as mean ± SE of tumor size.

Immunization with Vacc.polyLMP affords protection against LMP1-expressing EL4-A2/kb tumor cells.

Two groups of 10 mice were immunized with Vacc.polyLMP or Vacc.TK− (107 PFU/mouse), respectively. Twenty-one days after immunization, mice were challenged subcutaneously with EL4-A2/Kb-LMP1 cells (107 cell/mouse) and monitored for tumor size for 24 days after challenge. Data are presented as mean ± SE of tumor size.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal